These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1426 related articles for article (PubMed ID: 27210827)

  • 1. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
    J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice.
    Li L; Zhou N; Gong H; Wu J; Lin L; Komuro I; Ge J; Zou Y
    Hypertens Res; 2010 Dec; 33(12):1289-97. PubMed ID: 20944638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
    Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
    Dang Z; Su S; Jin G; Nan X; Ma L; Li Z; Lu D; Ge R
    J Ethnopharmacol; 2020 Mar; 250():112470. PubMed ID: 31862407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.
    Wang J; He W; Guo L; Zhang Y; Li H; Han S; Shen D
    Mol Med Rep; 2017 Aug; 16(2):1973-1981. PubMed ID: 28656296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of cardiac ACE2/Mas expression and cardiac remodelling in rats with aortic constriction.
    Zhang Y; Li B; Wang B; Zhang J; Wu J; Morgan T
    Chin J Physiol; 2014 Dec; 57(6):335-42. PubMed ID: 25575522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sini decoction alleviates E. coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis.
    Liu J; Chen Q; Liu S; Yang X; Zhang Y; Huang F
    Life Sci; 2018 Sep; 208():139-148. PubMed ID: 29990483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan.
    Iwanami J; Mogi M; Tsukuda K; Wang XL; Nakaoka H; Ohshima K; Chisaka T; Bai HY; Kanno H; Min LJ; Horiuchi M
    Hypertens Res; 2014 Jul; 37(7):616-20. PubMed ID: 24599018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats.
    Klimas J; Olvedy M; Ochodnicka-Mackovicova K; Kruzliak P; Cacanyiova S; Kristek F; Krenek P; Ochodnicky P
    J Cell Mol Med; 2015 Aug; 19(8):1965-74. PubMed ID: 25766467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.
    Xiao HL; Li CS; Zhao LX; Yang J; Tong N; An L; Liu QT
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1159-1169. PubMed ID: 27449068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice.
    Nakamura K; Koibuchi N; Nishimatsu H; Higashikuni Y; Hirata Y; Kugiyama K; Nagai R; Sata M
    Hypertens Res; 2008 Oct; 31(10):1953-61. PubMed ID: 19015603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
    Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
    Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
    Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M
    Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ACE-2/Ang1-7/Mas cascade enhances bone structure and metabolism following angiotensin-II type 1 receptor blockade.
    Abuohashish HM; Ahmed MM; Sabry D; Khattab MM; Al-Rejaie SS
    Eur J Pharmacol; 2017 Jul; 807():44-55. PubMed ID: 28442323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
    Pernomian L; Pernomian L; Baraldi Araújo Restini C
    Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.
    Sukumaran V; Veeraveedu PT; Lakshmanan AP; Gurusamy N; Yamaguchi K; Ma M; Suzuki K; Kodama M; Watanabe K
    Free Radic Res; 2012 Jul; 46(7):850-60. PubMed ID: 22497476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan and captopril ameliorate pregabalin-induced heart failure in rats.
    Awwad ZM; El-Ganainy SO; ElMallah AI; Khattab MM; El-Khatib AS
    Toxicology; 2019 Dec; 428():152310. PubMed ID: 31629013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of angiotensin-converting enzyme 2 and Mas activation in inhibitory effects of angiotensin II Type 1 receptor blockade on vascular remodeling.
    Iwai M; Nakaoka H; Senba I; Kanno H; Moritani T; Horiuchi M
    Hypertension; 2012 Jul; 60(1):137-44. PubMed ID: 22665126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
    Yamamoto K; Ohishi M; Katsuya T; Ito N; Ikushima M; Kaibe M; Tatara Y; Shiota A; Sugano S; Takeda S; Rakugi H; Ogihara T
    Hypertension; 2006 Apr; 47(4):718-26. PubMed ID: 16505206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.